SCHEMBL26802185

SCHEMBL26802185

CC(=O)Nc1ccc2c(c1)nnn2C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 10/20 0.68
NPC1 O15118 8/20 0.68
KDM4E B2RXH2 9/20 0.67
HSD17B10 Q99714 6/20 0.67
ALDH1A1 P00352 5/20 0.67
HPGD P15428 1/20 0.67
RXFP1 Q9HBX9 1/20 0.64
MAPT P10636 6/20 0.61
SMN1; SMN2 Q16637 5/20 0.61
HTT P42858 1/20 0.61
GLA P06280 2/20 0.58
NSD2 O96028 1/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
NPSR1 Q6W5P4 1/20 0.57
HCAR3 P49019 1/20 0.56
MAPK1 P28482 1/20 0.55
LMNA P02545 1/20 0.54
TNNI3 P19429 1/20 0.53
TNNT2 P45379 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19330719 0.88 NSD2 (0.58) RAB9ANPC1KDM4EHSD17B10ALDH1A1
SCHEMBL11055398 0.84 MAPT (0.56) RAB9ANPC1KDM4EHSD17B10ALDH1A1
SCHEMBL17910004 0.84 RAB9A (0.57) RAB9ANPC1KDM4EHSD17B10ALDH1A1
SCHEMBL3731059 0.83 NPC1 (0.55) RAB9ANPC1KDM4EHSD17B10ALDH1A1
SCHEMBL10347621 0.83 MAPT (0.55) RAB9ANPC1KDM4EHSD17B10ALDH1A1
SCHEMBL13604179 0.82 RAB9A (0.77) RAB9ANPC1KDM4EHSD17B10ALDH1A1
SCHEMBL14087506 0.80 RAB9A (0.60) RAB9ANPC1KDM4EHSD17B10ALDH1A1
SCHEMBL26802269 0.80 MAPT (0.51) RAB9ANPC1KDM4EHSD17B10ALDH1A1
SCHEMBL12369468 0.79 HCAR3 (0.76) RAB9ANPC1KDM4EHSD17B10ALDH1A1
SCHEMBL8311808 0.78 RAB9A (0.56) RAB9ANPC1KDM4EHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381327-A1 REACTIVE CONJUGATES DEBIOPHARM RESEARCH & MANUFACTURING S.A. (CH) 2023-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381327-A1 REACTIVE CONJUGATES FCGR3B, FCGR1A, FCGR2A RAB9A 267/4885NPC1 1404/4885KDM4E 3268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.